ABSTRACT
Seven serotypes of foot-and-mouth disease virus (FMDV) are known and a vaccine prepared from one serotype does not provide protection against infection with the other six serotypes. There is also considerable antigenic variation within the individual serotypes, causing problems in control of the disease by vaccination.
The major immunogen in virus harvests is the intact virus particle, which is icosahedral, is 30 nm in diameter, and consists of one molecule of single-stranded RNA surrounded by 60 molecules of each of four proteins, VP1-4. The immunodominant site, situated within residues 141-160 of VP1 (1) , is located on an exposed, flexible loop comprising amino acids (2) . Peptides corresponding to sequences within this loop are highly immunogenic and provide protective immunity in experimental animals.
This region, which includes the conserved cell attachment site Arg-Gly-Asp at residues [145] [146] [147] (3) , is highly variable in both sequence and antigenicity, thus providing an opportunity for studies on the structural basis of antigenic variation. Several variants have been isolated from a virus of serotype A, subtype 12, which differ only at positions 148 and 153 of VP1 (4) . Preliminary analysis by circular dichroism (CD) spectroscopy pointed to structural differences in two of these variants (5) . Seven of the viruses (Table 1 ) have now been analyzed in detail by serological methods using antisera against the 141-160 region. Synthetic peptides corresponding to this region have been studied by CD and molecular modeling to determine whether their structures correlate with the serological differences. Leu Leu Ser Gln Leu The sequence of the immunodominant loop from 133 to 160 is Gly-Thr-Asn-Lys-Tyr-Ser-Ala-Ser-Gly-Ser-Gly-Val-Arg-Gly-Asp-(*)-Gly-Ser-Leu.Ala-(*)-Arg-Val-Aba-Arg-Gln-Leu-Pro. Bold letters indicate the synthetic peptide sequences (residues 141-160); asterisks indicate the substituted positions at 148 and 153.
MATERIALS AND METHODS
Peptides were synthesized and purified as described (5) . Anti-peptide sera were prepared in guinea pigs with each peptide linked to bovine serum albumin as carrier. Reactivity between each antiserum and each virus and peptide was measured by radioimmunoprecipitation and ELISA, respectively (6) .
Peptide samples for CD measurements were prepared in 10 mM sodium phosphate buffer (pH 7.0) or in 1009% 2,2,2-trifluoroethanol (TFE). CD and absorption spectra were measured simultaneously at 250C from 330 nm to 178 nm at 0.5-nm intervals (7, 8) . Peptide concentrations were determined by using the amide extinction coefficient at 205 nm, after correction for phenylalanine content (9) . Optical path lengths were varied from 4 ,um to 1 mm; a Gray cell (10) was used to obtain path lengths < 100 ,um. The spectrometer and optical path lengths were calibrated as described (11 (Fig. 1A) , structural analysis of the CD spectra shows no significant differences among the peptides, which consist predominantly of 8A-strands (--28%), (3-turns (=23%), and "other" structures (-39%), as expected for random-coil peptides (17) . Moreover, in aqueous solution the structural content of each peptide is independent of concentration. Values for each antiserum are expressed as percentages of the homologous reaction. Boldface numbers indicate antigenic similarity (both heterologous reactions involving a pair of viruses are -32%). TFE, a weak hydrogen-bonding agent with a low dielectric constant (26 at 25°C) relative to water, can be used to induce periodic secondary structure (particularly a-helices) in peptides (18) . Furthermore, the a-helix content ofpeptides which form amphiphilic a-helices is expected to be concentrationdependent, since the latter structure is stabilized by intermolecular interactions (19) .
CD spectra were measured in 100% TFE at five to eight peptide concentrations. These spectra display maxima at 190 nm, minima at 208 nm, and negative bands at 220 nm, typical of a-helix (Fig. 1B) . Analysis of these spectra indicates that all seven peptides show increases in a-helix and (-turn, and decreases in (3-strand (,PA + (Bp) and "other" structures, with increasing peptide concentration (Table 4 ). An isodichroic point occurs at 198 nm in each of these sets of CD spectra (e.g., Fig. 1B) , indicating a two-state transition. Isodichroic points for helix-to-sheet, helix-to-coil, and sheet-to-coil transitions are observed at approximately 198 nm, 204 nm, and 208 nm, respectively, in CD spectra computed by Greenfield and Fasman (20) , suggesting that a sheet-to-helix transition occurs for each peptide in TFE as the peptide concentration increases. In fact, the increase in a-helix content for each peptide is equal to the decrease in (-strand content (PBA + Bp), to within 4% of the total structural content (Table 4 ).
In Fig. 2 which was fit to the data by allowing amin, am.,,, and Hto float ( proline, but highly sensitive to any substitution used here (serine, phenylalanine, leucine) at position 148. While the helix-forming parameters for FL, FS, and FQ are generally intermediate between those of SL and LL, they are closer to those of SL than to those of LL, consistent with the ELISA data. Also, under all conditions investigated here, each peptide invariably shows -15% /3-turn content. This fraction is equivalent to one P-turn, suggesting the possibility that a conserved j-turn exists among these peptides.
Structure-Site Predictions. All seven peptides are predicted to contain a-helices and &pturns in the C-and N-terminal regions, respectively (Fig. 3) (14) . Moreover, each predicted a-helix contains a region for which the psheet prediction is nearly as strong as that for a-helix, consistent with the idea of a sheet-to-helix transition. Finally, while all the peptides are predicted to contain at least one p-turn at the cell attachment site, all but LL and LP are predicted to contain overlapping p-turns at this site.
A helical wheel projection of residues [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] indicates that this region can form a highly amphiphilic a-helix (Fig. 4 (Fig.  5) , based upon the CD data (Table 4 , high peptide concentrations). The entire loop [residues 133-159 for serotype A12 (Table 1) ] was used, so that distance restraints could be applied to take advantage of the relative positions of the residues at the base of the loop, specified in the serotype 0 structure (2) . Sites for a-helices, P-strands, and P-turns were selected as indicated by Chou-Fasman analysis (14) and the sensitivity of am. to residue 148 and Pro-153. For FP and LP, it is likely that hydrophobic and van der Waals interactions between residue 148, Leu-151, and Ala-152 nucleate and stabilize the a-helix, while terminates the helix, since proline frequently occurs at the first position on the C-terminal side of an a-helix C-cap residue (15) . In FP and LP, the helices are extended to Asp-147 and Gly-146, respectively. Aspartic acid and glycine frequently occur at the N-cap position of a-helices (15) , and the presence of Asp-147 within the first turn at the N-terminal stabilizes the helix by interacting favorably with its net dipole moment (23) .
The simplest interpretation of the CD data is that the FL and LL a-helices behave like those of FP and LP, respectively, at the N-cap regions but extend to include Val-155 as the C-cap residue. These predictions place Arg-154 in the last helical turn at the C-terminal end, where its positively charged side chain interacts favorably with the helix net dipole moment. For SL, the CD data and helical wheel projection suggest that Ser-148 is excluded from the a-helix. Use of site-specific indices (15) to locate the most probable position for an a-helix containing seven amides yields residues 149-156 with Gly-149 and Ala-156 as N-cap and C-cap residues, respectively. The hydrophobic moments of these postulated a-helices are all (except LP) -87% of values expected for highly amphiphilic surface-seeking a-helices (16 Dihedral angles within the predicted a-helices, P-strands, and inverse yturns were restrained to within 100 of average values (24) (25) (26) , and the first and fourth a carbons of each predicted p-turn were restrained to a distance of4-7 A. Each model was subjected to energy minimiztion, followed by molecular dynamics at 900 K, saving one structure every 2.5 ps until 20 structures were generated. The latter structures then underwent molecular dynamics for 5.0 ps as the temperature was reduced to 300 K, followed by energy minimization. The process was repeated with different initial velocities, generating a total of 40 structures per peptide, from which the structure with the lowest relative free energy was selected.
These model structures (Fig. 5) are compact, with a mean value of 2.1 ± 0.1 for the ratio of solvent-accessible surface area to the surface area of a sphere of equal volume. The average value ofthis ratio for globular proteins is 2.0 (27) . Four of the five structures contain type II and type II' p-turns (26, 28) at the cell attachment site. The root-mean-square deviations for the superpositions of the a carbons of residues 146-157 ofeach ofthe five models on each other are consistent with the serological data. That is, the lowest values (rootmean-square deviation ' 3.4 A), indicating structural similarity, are observed for superpositions of SL, FL, and LL in one group and for LP and FP in a second group.
In each model, the eight residues with the largest solventaccessible surface area (29) in the region from 146 to 157 comprise 85-89%o of the entire surface area of this region.
These residues include Asp-147, residue 148, Ser-150, Leu-151, residue 153, Arg-154, Val-155, and Arg-157, except in the case of FL where Ala-156 is more exposed than Phe-148.
These surface areas range from 525 to 701 A2, somewhat larger than the contact surface area observed for one 19-residue peptide complexed with its anti-peptide Fab' (460 A2) (30) .
These models suggest that the residues cited above include those most likely to make contact with the antibody paratope. (18, 30) . Apparently, a nonaqueous environment, such as the solvent TFE or the close proximity of an antibody molecule, is required for the immunological specificity of these peptides to be expressed. This is not unexpected, since the affinity constant of an antigen-antibody complex depends upon noncovalent interactions which occur at the interface between the two molecules, and it is likely that water molecules are excluded from this region (30) . The correlation between the helix-forming parameters of these peptides, as measured by CD, and the serological results discussed here strongly suggests that helix formation plays a governing role in antigen-antibody interactions for the serotype A12 virus.
Our main reason for investigating the structural basis of antigenic variation in FMDV was to design a peptide which could induce antibodies that crossreact with several antigenic variants. Such a peptide needs only to possess the ability to complex with each ofthe corresponding B-cell receptors. Our serological data indicate that these anti-peptide sera can accommodate a wide range of steric and electrostatic properties in the side chain of the residue at position 153 (leucine, serine, glutamine), but not in the polypeptide backbone (proline). Glycine possesses the largest range of sterically accessible 4, i dihedral angles of any amino acid and is frequently found in flexible regions of proteins. Like proline, glycine tends to avoid a-helices (14, 15) . On the other hand, glycine residues in proteins are buried nearly twice as often as they are exposed (31) . It is possible that glycine at position 153 would allow the peptide backbone to access any configuration required by the B-cell receptors corresponding to viruses with or without .
A substitution at position 148 which would increase the crossreactivity between variants is more difficult to assess, since these anti-peptide sera are sensitive to the difference between phenylalanine and leucine at 148 but not to that between phenylalanine and serine at 148. It is possible that methionine could retain the flexible, hydrophobic properties of leucine, while providing some of the hydrogen-bonding capability (although more limited) of serine. Thus, one highly adaptable, "master key" peptide with the ability to bind to a number of B-cell receptors for serotype A12 might provide protection against a number of antigenic variants.
